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Abstract
Decellularized human adipose tissue has potential clinical utility as a processed biological scaffold
for soft tissue cosmesis, grafting and reconstruction. Adipose tissue decellularization has been
accomplished using enzymatic-, detergent-, and/or solvent-based methods. To examine the
hypothesis that distinct decellularization processes may yield scaffolds with differing
compositions, the current study employed mass spectrometry to compare the proteomes of human
adipose-derived matrices generated through three independent methods combining enzymatic-,
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detergent-, and/or solvent-based steps. In addition to protein content, bioscaffolds were evaluated
for DNA depletion, ECM composition, and physical structure using optical density, histochemical
staining, and scanning electron microscopy (SEM). Mass spectrometry (MS) based proteomic
analyses identified 25 proteins (having at least two peptide sequences detected) in the scaffolds
generated with an enzymatic approach, 143 with the detergent approach, and 102 with the solvent
approach, as compared to 155 detected in unprocessed native human fat. Immunohistochemical
detection confirmed the presence of the structural proteins actin, collagen type VI, fibrillin,
laminin, and vimentin. Subsequent in vivo analysis of the predominantly enzymatic- and
detergent-based decellularized scaffolds following subcutaneous implantation in GFP+ transgenic
mice demonstrated that the matrices generated with both approaches supported the ingrowth of
host-derived adipocyte progenitors and vasculature in a time dependent manner. Together, these
results determine that decellularization methods influence the protein composition of adipose
tissue-derived bioscaffolds.

Author Manuscript
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INTRODUCTION

Author Manuscript

Currently, plastic surgeons employ human adipose tissue as a surgical graft in wound repair,
cosmetic and reconstructive surgeries; however, it may have broader applicability as an
adjunct therapeutic [1]. More specifically, additional applications may include serving as a
vehicle promoting the delivery of drugs, growth factors and/or stem cells, as well as
representing an abundant and expendable extracellular matrix (ECM) source for generating
bioscaffolds for both autologous and allogeneic transplantation to promote tissue
regeneration in patients requiring cosmetic or reconstructive surgery for genetic defects of
the breast and chest wall (Poland syndrome) [2], facial deformities (Treacher Collins
syndrome) [3], facial lipoatrophy [4] or traumatic scar repair [5, 6]. Researchers have begun
to develop decellularized adipose tissue products in efforts to improve long-term graft
acceptance, differentiation, survival of transplanted stem cells and tissue regeneration [7-32].
Indeed, recent studies have demonstrated that decellularized adipose tissue derived
bioscaffolds can promote the proliferation and differentiation of exogenous stromal/stem
cells as evidenced by the expression of adipogenic lineage-specific genes in vitro, including
PPARγ, C/EBPα, and LPL [8, 12, 29].

Author Manuscript

To extend these outcomes in a reproducible and reliable manner, it will be necessary to
further define the composition of decellularized human adipose tissue products. One of the
most desirable features of a decellularized tissue product would be its retention of bioactive
ECM components such as proteoglycans and proteins including collagens, laminins,
fibronectin, and elastin [33]. Decellularization processes will inevitably cause disruption in
the ECM resulting in the loss of some proteins in addition to lipids, membranes and nucleic
acids. Although these decellularization processes vary, most include enzymatic digestion,
mechanical, and/or chemical extractions. The existing literature concerning protein analyses
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of decellularized tissues, including adipose tissue, describes the occurrence of specific ECM
proteins such as collagens and elastin, whose presence has been verified by biochemical and
immunohistochemical assays [8, 12, 34].
Characterization of the adipose tissue-derived biological scaffold at the protein level is
essential to understanding its utility, activity, and functionality. The current study compares
adipose-derived bioscaffolds prepared using enzymatic-, detergent-, and solvent-based
methods. The bioscaffolds were analyzed using three complementary in vitro approaches;
histological and spectrophotometric evaluation of decellularization, qualitative
ultrastructure, and ECM protein identification by mass spectrometry. In addition, an in vivo
analysis of the functionality of the enzymatic and solvent based bioscaffolds was performed.

METHODS
Author Manuscript

All methods involving human samples were carried out under a protocol approved by the
Pennington Biomedical Institutional Review Board (Baton Rouge, LA; PBRC#23040) or the
Western Institutional Review Board (Puyallup WA: WIRB Protocol #20130449). Samples
were obtained from male and female donors (n = 6) aged 43+/-9.3, with an average BMI of
23.3+/-2.9 kg/m2. All subjects gave written informed consent prior to collection of their
tissues. The hexafluorisopropanol (HFIP)-treated silk scaffolds were obtained from the
Tissue Engineering Resource Center, Tufts University (http://ase.tufts.edu/terc/) and
implanted as previously described [35].
Decellularization

Author Manuscript

The adipose tissue samples were divided and processed using three different
decellularization methods.

Author Manuscript

Enzymatic-based Method 1 (M1)—Tissue samples were decellularized using a method
developed and published by Flynn [8]. Intact adipose tissue was cut into 20-25 g pieces and
subjected to three cycles of freeze-thaw (-80°C to 37°C) in Freezing Buffer Solution (10
mM Tris buffer (pH 8.0), 5 mM ethylenediaminetetraacetic acid (EDTA). The tissue was
transferred into Enzymatic Digestion Solution #1 (0.25% trypsin/0.1% EDTA), and
incubated with agitation overnight for ~16 hrs followed by a 48 hr polar solvent extraction in
absolute isopropanol to remove lipid content. Next the tissue was rinsed three times for 30
minutes in Rinsing Buffer Solution (8 g/L NaCl, 200 mg/L KCl, 1 g/L Na2HPO4, and 200
mg/L KH2PO4 (pH 8.0)), and then incubated for 6 hrs in fresh Enzymatic Digestion Solution
#1. Following enzyme digestion, the samples were washed 3 times in Rinsing Buffer
Solution. Next, the samples were transferred into Enzymatic Digestion Solution #2 (55 mM
Na2HPO4, 17 mM KH2PO4, 4.9 mM MgSO4·7H2O containing 150 U/ml DNase Type II
(from bovine pancreas), 0.125 mg/ml RNase Type III A (from bovine pancreas), and 20
Units/ml Lipase Type VI-S (from porcine pancreas)) for 16 hrs of processing (overnight).
The next day, samples were rinsed 3 times for 30 minutes in the Rinsing Buffer solution.
The samples were subjected to a final polar solvent extraction in absolute isopropanol for 8
hrs, rinsed 3 times for 30 minutes in the Rinsing Buffer solution and rinsed 3 times for 30
minutes in 70% ethanol. Finally, the samples were stored in sterile PBS supplemented with
1% antibiotic/antimycotic solution (ABAM) at 4°C.
J Biomed Mater Res A. Author manuscript; available in PMC 2019 September 01.
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Detergent-based Method 2 (M2)—Tissue samples were decellularized using a modified
detergent-based and xenoprotein-free method [12]. In this process, the tissue was washed in
distilled water (1 g/mL), by shaking, for approximately 10 minutes until the wash liquid was
clear. The sample was centrifuged at 1800 X g for 5 minutes at room temperature, and the
upper oil layer was discarded. The viscous suspension was treated with a buffered 1 M
solution of NaCl (0.0584 g/mL in 10 mM Tris), diluted 1:1 with the tissue, overnight in a
37°C shaker. The following day, the samples were centrifuged at 29.3 X g for 5 minutes at
4°C. The supernatant was decanted and the pelleted samples were rinsed with distilled water
for 24 hrs at 4°C with gentle shaking. The medium was replaced with fresh distilled water
the next morning, followed by continued gentle shaking at 4°C for 2 hours. The residue was
incubated in 1 mM EDTA overnight, at room temperature. The next day the samples were
centrifuged and washed with distilled water for 24 hours at 37°C while gently shaking.
Finally, the samples were subjected to lysis buffer (1% tergitol type NP-40, 0.1% SDS, 5
mM EDTA, 0.4 M NaCl, 50 mM Tris-HCl pH 8, 1 mM phenylmethylsulfonyl fluoride
(PMSF)) (1:1 vol∷vol) overnight at 4° C to remove any remaining intact cells, centrifuged
for 10 min, and washed with distilled water. Samples were stored in sterile distilled water at
4°C.

Author Manuscript

Urea-based Solvent Method 3 (M3)—Tissue decellularization matched steps for the
preparation of the commercially available ECM product, Matrigel™ as described by
Kleinman [36]. One hundred grams of frozen adipose tissue were thawed in 200 mL of 3.4
M NaCl buffer at room temperature. Individual samples from 2-3 donors were then
homogenized for dispersement, followed by centrifugation at 8,000 x g for 15 minutes at
4°C. The supernatant was discarded, the homogenization step was repeated, and 100 mL of
2 M urea buffer (buffered with Tris) was added to the homogenate before repeating the
homogenization step. The samples were stirred overnight at 4°C, centrifuged at 23,000 x g at
4°C for 20 minutes, and the thick supernatant was saved on wet ice. The pellets were
homogenized in 2 M urea buffer, centrifuged at 23,000 x g at 4°C for 20 minutes, and the
supernatant collected. The successive supernatants from a single donor were combined and
the pellets discarded. Next, the samples were dialyzed against two liters of tris buffered
saline (TBS) (50 mM Tris-Cl, 150 mM NaCl pH 7.5 supplemented with 1% chloroform to
minimize bacteria or spore contamination) for ≥ 4 hours. Samples were then dialyzed twice
more for ≥ 2 hours each time, against 2 liters of TBS, then dialyzed once more against 2
liters of PBS. In a sterile hood, the exterior of the dialysis bag was rinsed with 70% ethanol
before cutting one end. The dialyzed contents were transferred into sterile conical tubes, on
ice, and stored at 4°C until further use.

Author Manuscript

Bioscaffold Analyses
DNA extraction and quantitation—Following decellularization, all samples (n = 3 to 4
donors) were assayed for DNA content. In a 1.5 ml micro-centrifuge tube, a 300 mg sample
was combined with 700 μL of Lysis Buffer (50 mL of 1 M Tris at pH 8, 20 mL of 5 M NaCl,
5 mL of 0.5 M EDTA, 100 mL of 1% SDS, and distilled deionized (DD) water to a final
volume of 500 mL) or Proteinase Digestion Buffer (100 mM Tris pH 8.0, 200 mM NaCl, 5
mM EDTA, 0.2% SDS) containing 10 μl proteinase K (10 mg/ml Roche) and incubated
overnight at 55°C. The next day, the samples were extracted with 700 μL
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phenol:chloroform:isoamyl alcohol (25:24:1), vortexed and centrifuged at 16,873 X g for 10
minutes at room temperature. 500 μL of the supernatant was transferred to a fresh 1.5 mL
micro-centrifuge tube, combined with 500 μL absolute ethanol, and stored at −20°C for at
least 2 hours. The samples were then centrifuged at maximum speed for 15 minutes at 4°C
and the supernatant was discarded. Next, the resulting DNA pellet was washed with 900 μL
of 70% ethanol, air dried, and re-suspended in 100 μL elution buffer (EB). Samples were
stored at −80°C until use. DNA concentration was measured via optical density, on a
Nanodrop 1000. The final concentration was calculated as:
ng 1000uL 1mL
1g
ng
)
dry weight =
x
x
x(
uL
mL
g
1000mg
mg
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Histochemistry and Immunohistochemistry—To confirm decellularization and
assess microscopic tissue structure and composition, histochemistry and
immunohistochemistry were performed using modifications of previously published
methods [37, 38]. Bioscaffold samples were fixed in 4% paraformaldehyde (PFA) and
processed on a Thermo Scientific Excelsior ES Tissue processor. Serial sections of 5
microns were taken. Paraffin sections were stained with Hematoxylin and Eosin (H&E)
(Leica Microsystems, Buffalo Grove, IL) and a Masson’s Trichrome Staining Kit (Poly
Scientific, Bay Shore, NY) according to the kit specifications. The H&E staining was
performed using a Leica St 5020 Autostainer. Slides were scanned using a Hamamatsu
Nanozoomer Digital Pathology (NDP) system (Hamamatsu City, Japan.)

Author Manuscript
Author Manuscript

Immunohistochemical staining for collagen VI (rabbit polyclonal IgG (1:100 dilution)
Novus Biologicals NB120-6588), alpha smooth muscle actin (mouse monoclonal IgG2
(1200 dilution) Millipore MAB1522), and vitronectin (mouse monoclonal IgG (1:100
dilution) Millipore MAB1926) was performed as follows. Slides were warmed on a heating
platform at 57°C for 30 minutes immediately prior to deparaffinization. For
deparaffinization, slides were rinsed in the following solutions: Xylene - 2 times for 5
minutes, 100% EtOH - 2 times for 2 minutes, 95% EtOH - 2 times for 2 minutes, 70% EtOH
- 1 time for 2 minutes, 50% EtOH - 1 time for 2 minutes, and finally DD water - 1 time for 2
minutes. For antigen retrieval, tissue sections were washed twice for 5 minutes in 20 mM
Tris-HCl (pH 8.0) and incubated in a 0.4 mg/mL proteinase K solution (in Tris-HCl, pH 8.0)
for 15 minutes at 37°C in a humidified chamber. The slides were then rinsed liberally with
water, followed by two 5-minute washes in Tris-buffered saline with tween (TBS-T) (50 mM
Tris, 150 mM NaCl, 0.05% Tween in DD water, pH 7.6). For antibody staining, the sections
were covered with TBS + 10% normal serum (secondary antibody host) + 1% BSA and
incubated for 2 hours at room temperature in a humidified chamber. Next the primary
antibody was applied and the sections were incubated overnight at 4°C in a humidified
chamber. The next day the slides were rinsed 2 times for 5 minutes in TBS-T. The secondary
antibody (either goat anti-rabbit IgG or goat anti-mouse IgG at 1:200 dilution in TBS plus
1% BSA) was applied and the sections were incubated for 1 hour at room temperature in a
humidified chamber protected from light. The slides were then rinsed 2 times for 5 minutes
in TBS followed by a liberal water rinse. Coverslips were added with the fluorescencemaintaining mounting medium, Prolong+ DAPI (Life Technologies). Sections were imaged
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using a Nikon Eclipse TE300 with an Olympus DP70 color camera in the Microbiology and
Immunology microscopy core at the Tulane University School of Medicine.

Author Manuscript

Triglyceride Measurement—To assess residual lipid content following decellularization,
measurements were made using a Triglyceride Colorimetric Assay kit (#10010303; Cayman
Chemical Inc., Ann Arbor, MI). 350-400 mg of cryomilled tissue samples were minced in 2
mL of the diluted Standard Diluent containing Halt™ protease inhibitor cocktail (Thermo
Scientific™). The samples were then centrifuged at 10,000 x g for 10 minutes at 4°C. The
supernatant was transferred to a second tube and stored on ice. Samples were diluted 1:10,
1:25, 1:50, and 1:100 using the diluted Standard Diluent. Assays were prepared using 10 μL
of standard or sample in each well of a 96 well plate. The reaction was initiated by the
addition of 150 μL of diluted Enzyme Buffer solution to each well. The microtiter plate was
shaken to mix the contents of the wells, covered, and incubated for 15 minutes at room
temperature. Absorbance was measured at 540 nm on a BioRad Benchmark Plus™ plate
reader.
Scanning Electron Microscopy—To assess tissue ultrastructure, electron microscopy
was performed using a modification of published methods [8, 11]. In preparation for
imaging under SEM, a ~15 mg piece of each bioscaffold was fixed in 0.2 M cacodylate at
room temperature overnight, followed by dehydration in an increasing acetone concentration
solution series (30% to 100%). The sample was then dried by replacing acetone with CO2
gas and sputter-coated with platinum for 4 minutes. The samples were then imaged in the
Socolofsky Microscopy Center, Louisiana State University on a JSM-6610LV scanning
electron microscope.

Author Manuscript

Mass Spectrometry and Peptide Identification
Mass spectrometry and peptide analyses were performed using a modification of published
methods [39].

Author Manuscript

Trypsinization—Protein samples were digested with sequencing grade modified trypsin
(Promega Corp) according to the manufacturer’s instructions. Briefly, 45 μL of 200 mM
triethyl ammonium bicarbonate (TEAB) was added to aliquots of 100 μg of protein sample
and the final volume was adjusted to 100 μL with ultrapure water. To solubilize complex
protein mixtures, 5 uL of 2% SDS was added before adjusting to final volume. Five
microliters of 200 mM Tris (2-carboxyethyl) phosphine (TCEP) was added and the resulting
mixture was incubated for 1 h at 55° C, then 5 μL of 375 mM iodoacetamide was added and
the mixture was incubated for 30 minutes without light. After incubation, 1 mL of prechilled acetone was added and the precipitation was allowed to proceed overnight at −20° C.
The acetone-precipitated protein pellets were suspended with 100 μL of 200 mM TEAB and
2.5 μg of trypsin was added to digest the sample overnight at 37 °C.
Fractionation of Labeled Peptide Mixture Using a Strong Cation Exchange Column
The peptide mixture was fractionated with a strong cation exchange column (SCX) (Thermo
Scientific) on a Shimadzu 2010 HPLC equipped with a UV detector (Shimadzu, Columbus,
MD). Mobile phase consisted of buffer A (5 mM KH2PO4, 25% acetonitrile, pH 2.8) and
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buffer B (buffer A plus 350 mM KCl). The column was equilibrated with Buffer A for 30
minutes before sample injection. The mobile phase gradient was set at a flow rate of 1.0 mL/
minute as follows: (a) 0 to 10 minutes: 0% buffer B; (b) 10 to 40 min: 0% to 25% Buffer B,
(c) 40 to 45 min: 25% to 100% Buffer B; (d) 45 to 50 minutes: 100% buffer B; (e) 50 to 60
minutes: 100% to 0% buffer B; (f) 60 minutes to 90 minutes: 0% buffer B. A total of 60
fractions were initially collected, lyophilized and combined into 15 final fractions based on
SCX chromatographic peaks.
Desalination of Fractionated Samples

Author Manuscript

A C18 solid-phase extraction (SPE) column (Hyper-Sep SPE Columns, Thermo-Fisher
Scientific) was used to desalt all collected fractions. The combined 15 fractions were each
adjusted to 1 ml final volume containing 0.25% (v/v in water) trifluoroacetic acid (TFA,
Sigma). The C18 SPE columns were conditioned before use by filling them with 1 mL
acetonitrile and allowing the solvent to pass through the column slowly (~3 minutes). The
columns were then rinsed three times with 1 mL 0.25% (v/v in water) TFA solution. The
fractions were loaded on to the top of the SPE cartridge and allowed to elute slowly.
Columns were washed four times with 1 mL 0.25% TFA aliquots before the peptides were
eluted with 3 × 400 μL of 80% acetonitrile/0.1% formic acid (aqueous).
LC-MS/MS Analysis on LTQ-Orbitrap

Author Manuscript

Peptides were analyzed on an LTQ-Orbitrap XL instrument (Thermo-Fisher Scientific)
coupled to an Ultimate 3000 Dionex nanoflow LC system (Dionex, Sunnyvale, CA). High
mass resolution was used for peptide identification and high energy collision dissociation
(HCD) was employed for reporter ion quantification. The RP-LC system consisted of a
peptide Cap-Trap cartridge (0.5 × 2 mm) (Michrom BioResources, Auburn, CA) and a
prepacked BioBasic C18 PicoFrit analytical column (75 μm i.d. × 15 cm length, New
Objective, Woburn, MA) fitted with a FortisTip emitter tip. Samples were loaded onto the
trap cartridge and washed with mobile phase A (98% H2O, 2% acetonitrile and 0.1% formic
acid) for concentration and desalting. Subsequently, peptides were eluted over 180 minutes
from the analytical column via the trap cartridge using a linear gradient of 6–100% mobile
phase B (20% H2O, 80% acetonitrile and 0.1% formic acid) at a flow-rate of 0.3 μl/minutes
using the following gradient: 6% B for 5 minutes; 6–60% B for 125 minutes; 60–100% B for
5 minutes; hold at 100% B for 5 minutes; 100–6% B in 2 minutes; hold at 6% B for 38
minutes.

Author Manuscript

The LTQ-Orbitrap tandem mass spectrometer was operated in a data-dependent mode.
Briefly, each full MS scan (60,000 resolving power) was followed by six MS/MS scans
where the three most abundant molecular ions were dynamically selected and fragmented by
collision-induced dissociation (CID) using a normalized collision energy of 35%, and the
same three molecular ions were also scanned three times by HCD-MS2 with collision
energy of 45%. MS scans were acquired in profile mode and MS/MS scans in centroid
mode. LTQ-Orbitrap settings were as follows: spray voltage 2.0 kV, 1 microscan for MS1
scans at 60,000 resolution (fwhm at m/z 400), microscans for MS2 at 7500 resolution (fwhm
at m/z 400); full MS mass range, m/z 400–1400; MS/MS mass range, m/z 100–2000. The
“FT master scan preview mode,” “Charge state screening,” “Monoisotopic precursor
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selection,” and “Charge state rejection” were enabled so that only the 2+, 3+, and 4+ ions
were selected and fragmented by CID and HCD.
Database Search

Author Manuscript

The protein search algorithm used was Mascot v2.3.01 (Matrix Science, Boston, Ma).
Mascot format files were generated by the Proteome Discoverer 1.2 software (ThermoFisher Scientific) using the following criteria: database, IPI_Human.fasta.v3.77 (containing
89,422 entries and concatenated with the reversed versions of all sequences.); enzyme,
trypsin; maximum missed cleavages, 2; Static modifications, carbamidomethylation (+57
Da), N-terminal TMT6plex (+229 Da), lysyl TMT6plex (+229 Da). Dynamic modifications,
N-terminal Clnpyro- Glu (+17Da); methionine oxidation (+16 Da); STY phosphorylation
(+80 Da); Precursor mass tolerance was set at 20 ppm; fragment match tolerance was set at
0.8 Da. Peptides reported by the search engine were accepted only if they met the false
discovery rate of p < 0.05 (target decoy database), a Mascot ion score ≥30 for peptide
identifications was required.
Gene Ontology Analysis—Identification of retained proteins and associated molecular
mechanisms was performed through the free online data base DAVID Bioinformatics [40,
41] . Protein identifiers where converted to gene name prior to analysis and GOTERM BPFAT was used for each decellularization type.
In Vivo Implantation

Author Manuscript

Murine studies examining the implantation of the decellularized adipose tissue (DAT)
scaffolds were conducted in accordance with IACUC Protocol #4302 which had been
reviewed and approved by the Tulane University Institutional Animal Care and Use
Committee (IACUC) prior to the initiation of this work.

Author Manuscript

The DAT was cut into sections with the dimensions of 10 × 10 × 5 mm or 500 μL total
volume, rinsed repeatedly in 70% ethanol, and rehydrated twice in sterile PBS. Prior to
implantation, GFP+C57Bl/6 mice were anesthetized with 2% isoflurane in 2 L/minute of O2.
The dorsal hair was shaved and one 1 cm incision was placed in the midline dorsal skin of
the mice. The M1 and M2 decellularized adipose ECM as well as silk scaffolds were
carefully placed in subcutaneous pockets on the back of each animal using tweezers as
described in [42]. Each mouse received 4 implants (two per side bilaterally adjacent to the
spinal cord), with duplicate scaffolds prepared for each of three donors and a total of 12
mice in the study. All animals were housed in separate cages using standard husbandry
conditions of 12 h light/12 h dark, room temperature of 20° to 21°C and unlimited access to
food and water. The animals were sacrificed after three, six and nine weeks postimplantation and implanted scaffolds were collected within their surrounding tissues. The
explanted scaffold samples were fixed in 4% paraformaldehyde and processed on a tissue
processor (Thermo Scientific Excelsior ES Tissue processor). Serial sections of 5 μm were
stained with Hematoxylin and Eosin (H&E) (Leica Microsystems, Buffalo Grove, IL and
Leica St 5020 Autostainer). For the immunohistochemistry study, the paraffin embedded and
fixed sections were stained using GFP (Anti-GFP rabbit polyclonal antibody unconjugated 2
mg/mL 100 uL, Invitrogen Molecular Probes, Eugene, Oregon, USA), perilipin (Rb pAb to
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Perilipin A 110 uL, Abcam, Cambridge, MA, USA) and CD31 (DSHB Hybridoma Product
2H8, Ames, Iowa, USA) antibodies according to the protocol described in the
Histochemistry and Immunohistochemistry section above. Sections were imaged using Scan
Scope Console – Leica, Version 10.2.0.2314 and Image Scan Scope – Leica, Biosystems,
2006-2013, Version 12.1.0.5029 and Aperio eSlide Manager online desktop Scan Scope
Console software.
Statistics—Outcomes are reported as the mean ± standard deviation unless otherwise
indicated. Comparisons are based on the student t-test with significance defined as p < 0.05
performed with Excel (Microsoft, Redmond WA).

RESULTS
Author Manuscript

Decellularization and Physical Characterization

Author Manuscript

The three decellularized scaffold preparations, enzymatic-based Method 1 (M1), detergentbased Method 2 (M2), and solvent-based Method 3- Matrigel™ (M3), underwent
characterization studies to determine DNA content removal, resulting physical structure, and
retained protein composition. Following the decellularization steps, the bioscaffolds
displayed the following overall macroscopic appearances: whitish color with retention of
tissue volume (M1); yellowish color with contracted tissue volume (M2) and; whitish color
with loss of tissue architecture and appearance of a suspension (M3). Staining with H&E
and Masson’s trichrome was performed to qualitatively assess cell nuclei and tissue structure
in the untreated adipose tissue relative to the decellularized adipose tissues. Histochemical
staining documented the presence of nuclei in the untreated tissues, and a lack of nuclei
following the M1, M2 and M3 decellularization procedures (Figure 1). To further evaluate
the presence of retained nuclear content, optical density readings were taken for quantitative
measurements of genomic DNA remaining in the decellularized bioscaffolds relative to
untreated tissue (Table 1). Relative to the genomic DNA isolated from the untreated control
(281 ± 152 ng/μL), the M1 (47 ± 27 ng/μL) and M2 (37 ± 9 ng/μL) decellularization
methods significantly reduced the genomic DNA content while the M3 method (237 ± 221
ng/μL) did not. To evaluate residual lipid content following decellularization, lipid vacuole
shape and triglyceride content were next evaluated. Lipid vacuoles appeared as imperfect
spheres in M1 and M2 bioscaffolds, similar to that of native tissue; however, these structures
were less apparent within M3 scaffolds (H&E staining; Figure 1); this may reflect the
presence of urea in the M3 protocol or, alternatively, may be an artifact of sectioning.
Triglyceride measurements indicated that all three decellularization methods retained less
than fifty-percent of the triglyceride content relative to the untreated native tissue (Table 1).

Author Manuscript

To further evaluate the effect of decellularization, scaffolds prepared with all Methods were
stained with Masson’s Trichrome (Figure 1). The level of Masson’s Trichrome staining was
enriched following M1 and M2 decellularization methods but not M3 relative to the
untreated control. To qualitatively assess the collagen fiber structure in the processed
samples, scanning electron microscopy (SEM) was performed (Figure 1). SEM under M2
and M3 revealed a complex fibrous network with varied patterns and densities on the surface
of the bioscaffolds relative to the untreated control tissue. In contrast, SEM under M1
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appeared to display smaller collagen bundles; however, this may reflect regional differences
within the fixed specimen. To further determine the retained cell and matrix composition,
immunofluorescent staining for collagen VI, actin, and vitronectin was performed using M1
and M2 scaffolds (Figure 2). Consistent with mass spectrometry results, collagen VI gave
the strongest positive signal in control and decellularized tissues. In contrast, actin signal
was reduced in both M1 and M2 while vitronectin, although present in M1, was nearly
absent in M2 relative to the untreated tissue control. The M3 scaffolds were not examined
due to failure of the bioscaffold suspension to properly mount onto the slides.
Mass Spectrometry and Immunohistochemical Proteomic Characterization

Author Manuscript
Author Manuscript
Author Manuscript

Mass spectrometry proteomic analyses provided an unbiased global assessment of the
protein content of the bioscaffolds. The untreated tissue sample had a reading of 281
peptides; of these, 155 were identified by the detection of at least two (2+) peptides and 29
were associated with the detection of seven (7+) peptides (Table 2 and Supplementary Table
1). The M1 sample had a reading of 67 total peptides identified, with 25 having 2+ peptide
sequences detected and only one having 7+ peptides detected (Supplementary Table 2). The
M2 scaffold had a reading of 296 total peptides, 143 of which had 2+ peptides detected, and
30 of these had 7+ peptides detected (Supplementary Table 3). The M3 scaffold sample had
243 total peptides, with 102 having 2+ peptides detected and 15 having 7+ peptides detected
(Supplementary Table 4). We evaluated the top twenty peptides (by number of peptides
detected) from each sample for commonalities (Supplemental Table 5), as well as protein
localization comparisons (Figure 3). Comparisons of the top twenty peptides identified in
the untreated tissue and decellularized scaffolds by the different methods revealed that these
were localized to the blood, nucleus, cytoskeleton, extracellular space, other various
intracellular locales, and those whose locations were unidentified. Inquiries were performed
to identify key factors in the ECM composition and to determine if they were associated
with a pathological biomarker or pathway. No markers or pathways were identified that
associated with particular diseases or pathologies. DAVID bioinformatics was used to
identify gene ontology analysis based on the genes assumed or known to be associated with
the proteins identified by LC MS/MS, to determine functionality of the components of the
final scaffold products. Analysis of total protein content determined that constituents
remaining in all three scaffold preparation method products showed association with cell
adhesion, biological adhesion, wound response, protein complex assembly, and
macromolecular complex assembly- among others (Table 3). Full gene ontology lists of the
individual scaffold preparation methods can be found in the supplemental material
(Supplemental Table 6). Identification of protein ontology uniquely identified only with
tissue decellularization and not present in native tissue, demonstrated enrichment for
proteins associated with biological and cell adhesion as well as lipid metabolism and DNA
packaging. Proteins included within this are: Isoform 1 of Myosin-9, Basement membranespecific heparan sulfate proteoglycan core protein, Histone H3.3, Isoform 2 of Hormonesensitive lipase, collagen alpha-3(VI) chain isoform 4 precursor, and Possible J 56 gene
segment (Fragment). Finally, comparisons across all decellularization methods to identify
proteins uniquely enriched between the three methods demonstrated that M1 and M2
uniquely shared 66 proteins not found in either M3 or native tissue. M3 shared one protein
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uniquely with M2 (Ig kappa chain V-III region B6) and 2 proteins uniquely with M1
(Alpha-1-acid glycoprotein 2 and Annexin A5).
Bioscaffold implantation in vivo allowed repopulation with mature adipocytes
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Subcutaneous implantation was performed using the decellularized M1 and M2 adipose
scaffolds to determine their support of adipose tissue formation in vivo since they retained
intact ECM proteins and architecture in vitro; however, comparable studies were not pursued
using the M3 scaffolds due to the suspension nature of the M3 bioscaffold and its loss of the
intact tissue architecture during the decellularization process. The M1 and M2 scaffolds
were implanted subcutaneously into transgenic C57Bl/6 GFP+ mice (Figure 4 and
Supplemental Figure 1). The scaffolds were harvested at serial intervals (3, 6 and 9 weeks).
At necropsy, gross visualization of the decellularized adipose scaffolds indicated adipose
tissue formation equivalent to or more robust than that obtained with a silk scaffold control
(Supplemental Figure 1). Of note, the M1 and M2 decellularized adipose scaffolds retained
an architecture similar to native adipose tissue, while the control silk scaffolds constructs
were more fibrotic in appearance. This was confirmed histologically based on H&E staining
(Data not shown). The presence of functional adipose cells increased in a time dependent
manner after implantation based on staining for perilipin, a lipid vacuole membrane
associated protein (Figure 4). The newly formed adipocytes stained positive for GFP,
consistent with the ingrowth and repopulation of the scaffold by host origin cells (Figure 4).
Additionally, the scaffolds contained cells staining positive for CD31, a biomarker primarily
but not exclusively associated with endothelial cells (Figure 5). An intact, native fat pad
from transgenic GFP+ C57Bl/6 mice served as a positive control (Figures 4 and 5).

DISCUSSION
Author Manuscript
Author Manuscript

Recent studies have reported the preparation of decellularized adipose tissue extracellular
matrices; a comprehensive review of this literature has recently been published by Banyard
et al. [25]. While the majority of studies reported on a single decellularization approach, the
work by Brown et al., stands out as an exception. This publication compared three
independent methods distinguished based on their predominant reliance on enzymatic,
chemical or physical methods of decellularizing porcine adipose tissue [30]. They concluded
that the individual methods resulted in decellularized matrices that were distinct based on
biochemical and structural features. The current study has confirmed and extended these
approaches by evaluating human adipose tissues processed with three decellularization
methods relying on enzymatic, detergent, or solvent agents, respectively. The resulting
products were examined and compared based on in vitro and in vivo outcomes. Consistent
with recent mass spectrometry analyses of detergent-decellularized lung tissues, the current
findings suggest that the proteomic composition of adipose tissue-derived bioscaffolds is
affected by the chosen decellularization method and this may have implications with respect
to their utility and favorability for specific clinical translational applications [34].
Despite these differences in the complexity of the decellularized tissue proteome, the
physical structure of the decellularized adipose product using two methods (M1 and M2)
was highly similar based on SEM as well as histochemical analyses, including fibrous
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networks indicative of collagen bundles. Gene ontology analysis of the mass spectroscopic
proteomic profile was employed to explore the possible functionality of the extracellular
proteins remaining post-decellularization. All three scaffold preparations displayed common
functional features related to cell adhesion, biological adhesion, and response to wounding.
All of the aforementioned functions may prove to be desirable traits for a reconstructive or
regenerative bioscaffold product designed for a particular or unique application.
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Intact genomic DNA retained in decellularized tissues may prove to induce an immune
response and foreign body reaction by the host to scaffold implants. As such, Gilbert et al.
have suggested that 50 ng/mg dry weight is a part of the minimum criteria for effective
decellularization in terms of the amount of genomic DNA remaining in decellularized
biological scaffolds [43]. This value was approached with both M1 and M2 based on
spectrophotometric readings; however, Method 3 genomic DNA content exceeded this
threshold value. The absence or presence of visible nuclear structures based on H&E
staining complemented the spectrophotometric detection of genomic DNA.

Author Manuscript

Adipose tissue is distinguished from other tissue types due to its relatively high triglyceride
content. The decellularization methods were all expected to deplete triglycerides, albeit
through different mechanisms. Indeed, triglyceride content was found to be highest in
scaffolds prepared using the detergent based M2. The relative triglyceride content was
reduced using either enzymatic (M1) or solvent (M3) based approaches. The triglyceride
retention in the M2 product suggests that the method is less stringent with respect to lipid
removal. It remains be determined whether the triglyceride content of the decellularized
adipose product will impact its properties and utility for cosmetic and reconstructive surgery.
As triglycerides can act to induce adipogenesis at the expense of osteogenesis, the final
triglyceride content of the product may have potential benefits with respect to soft tissue
augmentation and reconstruction while being detrimental to bone repair [44].

Author Manuscript

An important feature of an ideal scaffold product is its retention of the ECM protein content
and the relative depletion of cytoplasmic and nuclear protein content [43, 45]. The
cellularized scaffolds displayed an enrichment of ECM proteins based on analyses of the
mass spectrometry proteomics. This is consistent with the findings based on histochemical
and SEM analyses, which suggested a well-maintained ECM following decellularization
independent of the method. Since a critical goal of decellularization is to yield a defined
ECM product, it was necessary to confirm that the major ECM structural proteins- collagen,
laminin, fibronectin and elastin were preserved following decellularization. Mass
spectrometry-based proteomic data from all three decellularization procedures revealed the
ubiquitous presence of type VI collagen, and a varying presence of laminin and fibronectin.
While elastin was not detected by mass spectrometry, this does not necessarily rule out its
presence since certain peptides may be masked by others and thus may not be uncovered
under this type of analysis. Indeed, the fact that high abundance proteins may interfere with
the detection of other protein features detected by protein labeling presents a possible
limitation to the current study. This can lead to a lack of labeling or a false minimal labeling
with subsequent low detection levels for low abundance proteins. Thus, the LC-MS/MS
findings herein represent only a subset of the total proteome contained within these
biological scaffolds. Future studies may need to selectively remove known high abundance
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proteins to improve sensitivity. Such an approach, using selective antibody depletion of high
abundance proteins identified in the top twenty hits, has been employed successfully in
analyses of human serum [46].
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Based on mass spectrometry, both the M2 and M3 scaffold preparations retained the largest
variety of extracellular matrix proteins relative to those detected within intact adipose tissue.
Additionally, M2 scaffold showed minimal retention of nuclear proteins. In contrast, M1
displayed a depletion not only of cytoplasmic and nuclear proteins, but resulted in a more
restricted subset of ECM proteins relative to those found in intact adipose tissue. In this
respect, M1 yielded the most “homogenous” decellularization product based on the diversity
of its ECM protein profile as compared to M2 and M3; however, the depletion of
cytoplasmic and nuclear associated proteins components could alter the biological features
of the M1 product. Consistent with this observation, Calle et al., using a quantitative [C13]
labeling mass spectrometry approach, found that the milder detergent based decellularization
methods differentially extracted and enriched lung matrix proteins [34]. Their comparison
found that the milder SDS/Triton X-100 detergent increased the yield of basement
membrane proteins, proteoglycans, and laminin relative to the harsher CHAPS based
decellularization [34]. Thus, the selection of a particular decellularization protocol can
significantly influence the composition of final extracellular matrix product. Furthermore,
the use of mass spectrometry modified to allow for quantitative measurements has merit for
future studies of the decellularized adipose matrix.
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Consistent with previously published studies using adipose-derived ECM prepared using a
variety of decellularization protocols [10, 11, 14, 15, 17, 20, 28, 32], implantation of
scaffolds prepared using M1 and M2 demonstrated the ability to promote formation of an
adipose depot in vivo. The implants displayed a time dependent infiltration of GFP+
adipocytes and vascular cells from the adjacent tissues that was accompanied by the
presence of characteristic mature adipocytes. While only a few scattered cell nuclei were
detected within the M1 and M2 scaffolds at earlier time points (3 weeks), the number of
nuclei present based on H&E staining increased considerably at later time points (9 weeks).
These preliminary in vivo studies validate the ability of M1 and M2 scaffolds to promote
native cell migration and de novo formation of soft tissue, confirming previous reports in the
literature [12, 17].
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The current study has several limitations that merit consideration with respect to future
experimentation. First, the MS-based proteomic methods employed were qualitative rather
than quantitative. The use of [13C] isotope labeled standards, as employed by Calle et al. in
analyses of the decellularized lung, could address this issue [34]. Additionally, label free
mass spectrometry methods have been developed which calculate the total protein injected
into the assay system and use this as a basis for quantifying individual peptide
concentrations [47]. Second, the current study examined only subcutaneous adipose tissue
from a limited number of lean (BMI < 25) donors. Future studies will need to compare the
mass spectrometrically identified proteome of subcutaneous to visceral and other adipose
depots from lean, overweight, and obese individuals. Baker et al. have pioneered such
studies by documenting the effect of decellularized extracellular matrix from visceral
adipose tissue on the metabolism of cultured pre-adipocytes from diabetic and non-diabetic
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subjects [48]. It will be informative to determine whether correlations exist between the
metabolic outcomes and the decellularized adipose ECM proteomes as a function of patient
disease. Finally, the current study did not address the biophysical and mechanical properties
of the decellularized adipose ECM as had been earlier addressed by Omidi et al. [18].
Studies correlating the elasticity, stiffness and compressive properties of the bioscaffolds to
the proteome as a function of donor and depot origin would extend the scope of the current
data.

Author Manuscript
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In summary, the decellularization methods explored in this study were chosen based on
fundamental differences in processing- enzymatic, detergent, and solvent. Each method
resulted in products with promising features. M1 generated a product with a more narrowly
focused subset of ECM proteins, yielding a product containing fewer identified cytoplasmic
and nuclear proteins relative to the other decellularization Methods. M2 successfully
generated a bioscaffold product isolated without the use of xenogeneic enzymes. This has
the potential to reduce the likelihood of a subsequent adverse immunologic response or
foreign body response to the implant by the patient or host. The M3 process was explored
since it mimics the process used to manufacture commercially available Matrigel™. Since
Matrigel™ has desirable thermolabile and biomaterial features, such as maintaining a liquid
form at low temperatures and a solid form at body temperature, a human adipose tissuederived bioscaffold would be desirable from a clinical translation perspective for treatments
requiring small volume injections; however, degradation of the matrix may interfere with its
utility in larger volume applications. Each of the individual methods has features which may
provide economies of scale in bioprocessing human adipose tissue commercially. Likewise,
each method has elements that may prove disadvantageous during the scale-up process.
Nevertheless, while further work will be necessary to define an optimal decellularization
method for large scale bioscaffold production, the current study demonstrates that
comparable ECM products can be obtained with varying combinations of enzymatic,
detergent, and solvent based decellularization approaches. Eventually, it may prove useful to
develop a robust and reliable quantitative mass spectrometry lot release assay for the
characterization and validation of large scale produced decellularized adipose tissue
matrices.

CONCLUSIONS

Author Manuscript

The objective of the current study was to compare the proteome of human adipose tissue
decellularized by multiple methods and to explore its potential application as a scaffold
promoting adipogenesis in vivo. Based on histological results, human adipose tissue can be
successfully decellularized using any of three methods involving a combination of
detergents, enzymes, and/or solvents. Based on mass spectrometric analyses, the resulting
scaffolds retain a common subset of extracellular matrix proteins; however, the retention of
cytoplasmic and nuclear proteins varies depending on the extraction methodology. In
confirmation of prior publications, two of the matrices displayed the ability to promote in
vivo adipose depot formation through the recruitment of host progenitor cells and
vasculature. In conclusion, multiple decellularization methods can be applied to human
adipose tissue to create a product with potential tissue engineering utility; however, the
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resulting proteome of the decellularized matrix varies dependent on the decellularization
method.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Microscopic Analysis of Untreated and Decellularized Adipose Tissue Samples. Untreated
control tissue and the products of the M1, M2, and M3 decellularization procedures were
evaluated by in H&E staining (top), Masson’s Trichrome stain (middle), and Scanning
Electron Microscopy (SEM) (shown at 1500 X magnification). Individual images are
representative of at least n = 3.
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Figure 2.

Immunofluorescent staining for collagen VI, actin, and vitronectin. Paraffin fixed slides
prepared with tissue from untreated controls or scaffolds decellularized using methods M1
and M2 were stained with fluorochrome labeled antibodies to collagen VI, actin, and
vitronectin. Images are representative of n =3.
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Figure 3.

Subcellular Localization of the Top Twenty Peptides (based on number of hits) in Each
Decellularized Scaffold Relative to Untreated Tissue Control.
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Figure 4.

Immunohistochemical Detection of Adipogenic Biomarker (Perilipin) and Host Cells (GFP)
in M1 and M2 Tissue Scaffold In Vivo Implants. Scaffolds were implanted into C57BL/6
mice transgenic for ubiquitous expression of the green fluorescent protein (GFP) for periods
of 3, 6, or 9 weeks (top, middle, or bottom panels). A native adipose tissue served as positive
controls for both antibodies.
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Immunofluorescent Detection of CD 31. demonstrated the vascularization of the implanted
scaffolds denoting their integration. Scaffolds were implanted into C57BL/6 mice transgenic
for ubiquitous expression of the green fluorescent protein (GFP) for periods of 3 or 6 weeks.
A silk scaffold implant and native adipose tissue served as positive controls. Sections were
stained with DAPI for detection of nuclei (blue) or anti-CD31 fluorochrome labeled
antibodies (red).
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Genomic DNA and Triglyceride Levels in Decellularized Human Adipose-Derived Scaffolds
Untreated

Decell M1

Decell M2

Decell M3

Genomic DNA (ng/μl)

281 ± 152

47 ± 21*

37 ± 9*

237 ± 221

Triglyceride (mg/dl)

56.8 ± 0.2

16.9 ± 0.1

23.7 ± 0.1

16.8 ± 0.1

Values are reported as the mean ± standard deviation of n = 3 samples from individual donors. Significance was calculated based on a one tailed
student t-test relative to the untreated control where (*) represents p value < 0.05.
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LC-MS/MS Peptides Identified with each Decellularization Method
Untreated

Decell M1

Decell M2

Decell M3

# Identified Peptides

281

66

296

242

# Identified with 2 Peptides

155

25

143

102

# Identified with 7 Peptides

29

1

30

15
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8
8
7
6
9

Cell Adhesion

Biological Adhesion

Response to Wounding

Protein Complex Assembly

Macromolecular Complex Assembly

24.3

16.2

18.9

21.6

21.6

%

M1

0.00024

0.0091

0.0022

0.0018

0.0018

P Value

25

18

19

32

32

Freq

12.6

9.1

9.6

16.2

16.2

%

M2

35
23
37
24

4 × 10−9
2 × 10−4
4.7 × 10−4
9.8 × 10−6

3×

35

Freq

10−9

P Value

14.1

10

12.9

20.6

20.6

%

M3

8.7 × 10−7

0.0003

3.1 × 10−8

1.1 × 10−13

1.1 × 10−133

P Value

Five functionality traits found in all three scaffold preparations. Category-= Gene Ontology (GO) term function description; Freq (Frequency) = number of genes represented which are related to the GO
term function; p values = probability of presence of number of genes (frequency) out of total number of genes of the particular function, related to the whole genome.

Freq

Category

Decell Method
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Gene Ontology Analysis of Decellularization Methods 1, 2, & 3 Scaffolds
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